Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Immunomedics Inc (IMMU)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Immunomedics's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Immunomedics historical data, for real-time data please try another search
87.86 0.00    0.00%
22/10 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 87.59 - 87.93
Immunomedics 87.86 0.00 0.00%

NASDAQ:IMMU Financials

 
A brief overview of the NASDAQ:IMMU financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Immunomedics over time.

For the six months ended 30 June 2020, Immunomedics, Inc. revenues increased from $0K to $20.1M. Net loss decreased 2% to $159.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Research and development decrease of 5% to $105M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.85 to -$0.73.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

IMMU Income Statement

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Total Revenue 20.07 0 0.29 0
Gross Profit 18.41 0.29 0
Operating Income -53.01 -81.97 -91.25 -86.77
Net Income -66.47 -93.05 -99.61 -94.29

IMMU Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Total Assets 1077.13 594.11 671.72 411.73
Total Liabilities 483.81 408.13 403.46 387.37
Total Equity 593.32 185.97 268.26 24.36

IMMU Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  -126.37%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Period Length: 6 Months 3 Months 12 Months 9 Months
Cash From Operating Activities -102.69 -71.87 -222.44 -129.78
Cash From Investing Activities -1.32 -0.47 -6.85 -6.51
Cash From Financing Activities 466.59 0.03 347.18 8.11
Net Change in Cash 362.56 -72.33 117.87 -128.21
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

IMMU Comments

Write your thoughts about Immunomedics Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jim Saco
Jim Saco Oct 14, 2020 5:42PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I bought 300 shares under 85 and cashed out today at $87.56. Since I was in the margin made sense for me to forgo $132 and take the $800 profit.
Reply
0 1
Report
ali ma
ali ma Oct 07, 2020 11:32PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
if I buy this share at current price@85 ... what will happen to my shares after the merge? my shares will be converted to gilead shares at what every price let say $65 + $88? so one share will be let say the current immu price $85- let say gilead$65 + 88? one share will be $153 instead of 173.does the symbol changes to gilead?
Reply
1 0
Report
Jim Herbert
Jim77 Oct 07, 2020 11:32PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
You will receive $88 cash for each share you hold. I don't think you'll receive Gilead shares.
Reply
0 0
Report
ali ma
ali ma Sep 29, 2020 3:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
🕷️ spider run run ... market crash is coming
Reply
2 1
Report
Jim Saco
Jim Saco Sep 18, 2020 1:51PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I bought 200 shares at $84.64. Can't walk away from a 3.8% gain, even if I have to wait a month or two.
Reply
1 0
Report
Jim Herbert
Jim77 Sep 18, 2020 1:51PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I believe it's a good move. Thinking about the same thing. Of course the only risk is the acquisition deal falling through (for whatever reason). In that unlikely case this would go back to $40-50 range.
Reply
0 0
Report
Jim Saco
Jim Saco Sep 18, 2020 1:51PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Jim Herbert Doubt it. Both boards approved it unanimously.
Reply
0 0
Report
Tejasvi Gogna
Tejasvi Gogna Sep 15, 2020 8:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Seems this will drop now
Reply
3 0
Report
Jim Herbert
Jim77 Sep 15, 2020 8:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Why really though? They are being acquired for $88 per share. Why would any shareholder sell significantly below that? There can be one reason: Betting on the acquisition decision by Gilead changing and it not happening eventually.
Reply
0 1
Report
Farhad Ahmad
Farhad Ahmad Sep 15, 2020 7:27AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Why is this stuck?
Reply
0 0
Report
Jim Herbert
Jim77 Sep 15, 2020 7:27AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Well, Gilead is gonna acquire them for $88 per share. So all shareholders will get $88 for each share they are holding. Currently why would anyone pay more than $88? Similarly, why would anyone sell it for less than $88? It should be stuck near $88 until the acquisition actually takes place in my opinion. Is this not the logic?
Reply
4 0
Report
Emmanuel Domingo
Emmanuel Domingo Sep 14, 2020 8:44PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
50 by friday hold tight going doen to china-town!!
Reply
4 0
Report
Ramone Bolton
Ramone Bolton Sep 14, 2020 1:34PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I put for put on it for like little 40 all 4 cast that I'm already up like 400 already but still I stand to lose 40 and to gain a couple 1000s so I'm good with that
Reply
4 1
Report
Ramone Bolton
Ramone Bolton Sep 14, 2020 1:31PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
in my opinion anyone why buy this today good luck because you see how all this month been from it start one minute the market is up then next it's not so I wouldn't dare jump in on a buy worse it's the first of it jumping up
Reply
2 0
Report
Farhad Ahmad
Farhad Ahmad Sep 14, 2020 1:26PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Law of gravity: What goes up must come down.
Reply
4 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email